Literature DB >> 10861206

Activation of extracellular signal-regulated protein kinase1,2 results in down-regulation of decorin expression in fibroblasts.

P Laine1, N Reunanen, L Ravanti, M Foschi, M Santra, R V Iozzo, V M Kähäri.   

Abstract

Decorin is a small leucine-rich extracellular matrix proteoglycan, the expression of which is down-regulated in proliferating and malignantly transformed cells. In the present study we show that the expression of decorin in fibroblasts is suppressed by epidermal growth factor (EGF) and PMA, and that the effect of both is potently inhibited by blocking the extracellular signal-regulated protein kinase (ERK)1,2 signalling pathway (Raf/MEK1,2/ERK1,2) with the specific MAPK/ERK kinase (MEK)1,2 inhibitor, PD98059. In addition, specific activation of ERK1,2 by adenovirus-mediated expression of constitutively active MEK1 in dermal fibroblasts results in marked reduction in decorin mRNA abundance and production. Co-transfection of NIH-3T3 fibroblasts with human decorin promoter/chloramphenicol acetyltransferase (CAT) construct (pDEC--879/CAT) in combination with the expression vectors for constitutively active Raf-1 and MEK1 markedly suppressed decorin promoter activity. Co-transfections of human decorin promoter 5'-deletion constructs with constitutively active MEK1 expression vector identified the region -278 to -188 as essential for ERK1,2 mediated down-regulation of decorin promoter activity. These results show that activation of the ERK1,2 signalling pathway by a mitogenic growth factor, a tumour promoter or transformation suppresses decorin gene expression in fibroblasts, which in turn may promote proliferation and migration of normal and malignant cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10861206      PMCID: PMC1221115          DOI: 10.1042/0264-6021:3490019

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

Review 1.  Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function.

Authors:  R V Iozzo; A D Murdoch
Journal:  FASEB J       Date:  1996-04       Impact factor: 5.191

2.  Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways.

Authors:  N Reunanen; J Westermarck; L Häkkinen; T H Holmström; I Elo; J E Eriksson; V M Kähäri
Journal:  J Biol Chem       Date:  1998-02-27       Impact factor: 5.157

3.  Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family.

Authors:  Y Wang; S Huang; V P Sah; J Ross; J H Brown; J Han; K R Chien
Journal:  J Biol Chem       Date:  1998-01-23       Impact factor: 5.157

4.  Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression.

Authors:  J T Bruder; I Kovesdi
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

5.  Biphasic activation of p21ras by endothelin-1 sequentially activates the ERK cascade and phosphatidylinositol 3-kinase.

Authors:  M Foschi; S Chari; M J Dunn; A Sorokin
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

6.  Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor.

Authors:  D K Moscatello; M Santra; D M Mann; D J McQuillan; A J Wong; R V Iozzo
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

7.  Functional characterization of the human biglycan 5'-flanking DNA and binding of the transcription factor c-Krox.

Authors:  A M Heegaard; P Gehron Robey; W Vogel; W Just; R L Widom; J Schøller; L W Fisher; M F Young
Journal:  J Bone Miner Res       Date:  1997-12       Impact factor: 6.741

8.  Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells.

Authors:  M Ahonen; A H Baker; V M Kähäri
Journal:  Cancer Res       Date:  1998-06-01       Impact factor: 12.701

9.  Identification of a bimodal regulatory element encompassing a canonical AP-1 binding site in the proximal promoter region of the human decorin gene.

Authors:  A Mauviel; K Korang; M Santra; D Tewari; J Uitto; R V Iozzo
Journal:  J Biol Chem       Date:  1996-10-04       Impact factor: 5.157

10.  Suppression of decorin expression and partial induction of anchorage-independent growth by the v-src oncogene in human fibroblasts.

Authors:  E Kolettas; R F Rosenberger
Journal:  Eur J Biochem       Date:  1998-06-01
View more
  5 in total

1.  RLP, a novel Ras-like protein, is an immediate-early transforming growth factor-beta (TGF-beta) target gene that negatively regulates transcriptional activity induced by TGF-beta.

Authors:  Ester Piek; Maarten Van Dinther; W Tony Parks; John M Sallee; Erwin P Böttinger; Anita B Roberts; Peter Ten Dijke
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

2.  Cholesterol, a Major Component of Caveolae, Down-regulates Matrix Metalloproteinase-1 Expression through ERK/JNK Pathway in Cultured Human Dermal Fibroblasts.

Authors:  Sangmin Kim; Jeonghun Han; Dong Hun Lee; Kwang Hyun Cho; Kyu Han Kim; Jin Ho Chung
Journal:  Ann Dermatol       Date:  2010-11-05       Impact factor: 1.444

Review 3.  Proteoglycans: pericellular and cell surface multireceptors that integrate external stimuli in the mammary gland.

Authors:  M Delehedde; M Lyon; N Sergeant; H Rahmoune; D G Fernig
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-07       Impact factor: 2.673

4.  Effect of connective tissue growth factor on protein kinase expression and activity in human corneal fibroblasts.

Authors:  Siva S Radhakrishnan; Timothy D Blalock; Paulette M Robinson; Genevieve Secker; Julie Daniels; Gary R Grotendorst; Gregory S Schultz
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-13       Impact factor: 4.799

Review 5.  Small Leucine-Rich Proteoglycans in Skin Wound Healing.

Authors:  Xiaoxiao Pang; Nuo Dong; Zhong Zheng
Journal:  Front Pharmacol       Date:  2020-01-28       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.